Trial Radar
Sign in

NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Study to IDEntify Patients With Advanced/Metastatic Non Small Cell Lung Cancer (NSCLC) and ALK and ROS1 Translocation and to Establish Their Therapeutic Management (IDEALK&ROS)
Study to IDEntify Patients With Advanced/Metastatic Non Small Cell Lung Cancer (NSCLC) and ALK and ROS1 Translocation and to Establish Their Therapeutic Management (IDEALK&ROS)

NCT02679170

CompletedN/A

Sponsor: Pfizer

Conditions: Non-Small Cell Lung Cancer

Interventions: Crizotinib

Countries: Spain

Prospective observational study to IDEntify patients with advanced/metastatic NSCLC and ALK and ROS1 translocation and to establish their therapeutic management (IDEALK\&ROS)

Eligibility overview

Sex: ALL

Age: 19 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria
Inclusion Criteria:

For ALK Incidence substudy

* Patients with Advanced or metastatic non-small cell lung cancer
* Patients who will be screened for anaplastic lymphoma kinase (ALK) rearrangement
* Age \> 18 years For ALK treatment substudy (retrospective and prospective)
* Age \> 18 years
* Confirmed anaplastic lymphoma kinase (ALK)-positive tumour
* Patients treated with crizotinib under routine clinical practice
* Patients with a minimum data registered at the medical history
* For the patients that will be recruited prospectively: Patients must have a signed informed consent document.

For the ROS1 treatment sub-study (retrospective only):

* Age \> 18 years
* Confirmation of NSCLC with ROS1-positive translocation
* Have been eligible to receive treatment with crizotinib according to routine clinical practice since the market launch of the ROS1 indication in Spain on 8 February 2017 until the opening of the site.
* Patients should have a predetermined minimum amount of data recorded in their medical records.

Exclusion Criteria:

* Any patient who does not meet any of the inclusion criteria defined in the previous section, depending on the sub-study for which they are included.
Locations (32)
  • Santiago de Compostela, A Coruña, Spain
  • Alcoy, Alicante, Spain
  • Jerez de la Frontera, Cadiz, Spain
  • Santander, Cantabria, Spain
  • Alcázar de San Juan, Ciudad REAL, Spain
  • Las Palmas de Gran Canaria, LAS Palmas, Spain
  • Pamplona, Navarre, Spain
  • Barakaldo, Vizcaia, Spain
  • Albacete, Spain
  • Barcelona, Spain
  • Burgos, Spain
  • Cadiz, Spain
  • Jaén, Spain
  • Las Palmas de Gran Canaria, Spain
  • León, Spain
  • Logroño, Spain
  • Lugo, Spain
  • Madrid, Spain
  • Madrid, Spain
  • Madrid, Spain
  • Madrid, Spain
  • Madrid, Spain
  • Málaga, Spain
  • Murcia, Spain
  • Ourense, Spain
  • Oviedo, Spain
  • Palma de Mallorca, Spain
  • Santa Cruz de Tenerife, Spain
  • Seville, Spain
  • Toledo, Spain
  • + 2 more on CT.gov